Sabinsa, the multi-national health science company known for providing sustainable natural, well-researched ingredients, will be exhibiting at the International Food Ingredients & Additives (IFIA) Expo from May 22–24, 2024, at the Tokyo Big Sight Exhibition Center. The expo primarily focuses on functional foods, dietary supplements, and natural ingredient categories, and is a significant platform for food ingredient manufacturers.

Sabinsa’s technical and marketing team will be available in booth #1325, South Hall, to describe Sabinsa’s top-selling and trending products. Products to be featured at the expo include:

• Curcumin C³ Complex®, obtained from the dried rhizomes of Curcuma longa and standardized for a minimum of 95% Curcuminoids.
• BioPerine®, a natural bioavailability enhancer, standardized for minimum 95% Piperine.
• C3 Reduct®, a cascading antioxidant with cumulatively stronger activity compared to parent Curcuminoids for maintaining organ health.
• LactoSpore®, Bacillus coagulans MTCC 5856, the popular clinically validated, GRAS affirmed, shelf-stable probiotic.
• Saberry®, a multifaceted phytonutrient from amla fruit standardized to the powerful antioxidant molecule beta-glucogallin, and clinically studied for blood sugar support.

Other Sabinsa products that are of major interest to formulators, such as Salaretin® and Boswellin®, will be on display at the expo.

Sabinsa will also host educational seminars on its novel ingredients that are gaining popularity in nootropic and weight management categories:

• On May 23, 2024, between 1:30 PM – 1:45 PM, Taku Yoshiki, Senior General Manager, Sabinsa, will present the science behind its innovative ingredients that are used in nootropic applications, including Bacopin®, Sabroxy®, Centellin®, Curcumin C³ Complex®, etc.
• On May 24, 2024, between 2:30 PM – 2:45 PM, Tatsuya Maruyama, Sales Manager, Sabinsa, will present the key ingredients from Sabinsa for diet and weight management, including Terminalia bellirica, Salaretin®, Citrin®, Garcitrin®, and Fabenol®.

At the event, Sabinsa will debut various prototype formulations, including White Curcuminoid Chewable tablets, LactoSpore® and DigeZyme® Chewable tablets, Curcumin C³ Complex gummies, and other innovative formulations. These prototypes are formulated to meet diverse health support applications, including immune support, digestive health, antioxidant and anti-inflammatory support, etc.

Mr. Shaheen Majeed, Global Managing Director and CEO of Sami-Sabinsa Group, stated, "I am looking forward to meeting with our Japanese partners and assisting them with our breakthrough solutions at the expo. I anticipate that the event will further strengthen our relationships with customers and add to Sabinsa’s growth momentum in Japan."

Note: BioPerine®, C³ Complex®, Bacopin® is a Registered Trademark of Sabinsa Corporation, USA
White Curcuminoids®, Lactospore®, Boswellin®, Salaretin®, Saberry®, Sabroxy®, Centellin®, Citrin®, Garcitrin®, Fabenol®, DigeZyme® is a Registered Trademark of Sabinsa Japan Corporation